Halocur

País: Nueva Zelanda

Idioma: inglés

Fuente: Ministry for Primary Industries

Ingredientes activos:

halofuginone base

Disponible desde:

Schering-Plough Animal Health Limited

Designación común internacional (DCI):

halofuginone base

Composición:

halofuginone base 0.5 g/litre

Área terapéutica:

Coccidiostat

Estado de Autorización:

ACVM Registered

Fecha de autorización:

2008-05-27

Ficha técnica

HALOCUR
490 mL and 980 mL – Label and Label fix-a-form
A009802
Page 1 of 6
HALOCUR
29 Jun 2021
Label – 490 mL, Front
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
HALOCUR
®
ORAL SOLUTION FOR TREATMENT OF _CRYPTOSPORIDIUM_ IN CALVES.
ACTIVE CONSTITUENT: 0.5 G/L HALOFUGINONE BASE (AS LACTATE SALT).
INDICATIONS
For the prevention and treatment of diarrhoea caused by
_Cryptosporidium parvum_.
READ ENTIRE LABEL BEFORE USE.
ACVM No. A009802.
CONTENTS: 490 ML
BATCH NO.
EXPIRY DATE
MSD AH logo
HALOCUR
490 mL and 980 mL – Label and Label fix-a-form
A009802
Page 2 of 6
HALOCUR
29 Jun 2021
Label – 490 mL, Fix-a-form (Front cover)
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
HALOCUR
®
WITHHOLDING PERIODS: Cattle (Meat): 28 days.
NOT FOR USE IN BOBBY CALVES.
WARNING. Harmful to aquatic life. Harmful if inhaled. Causes eye
irritation. May cause
liver/kidney damage.
READ ENTIRE LABEL BEFORE USE.
MSD AH logo
Label – 490 mL [980 mL], Fix-a-form (Pages 2 – 6)
ACTIVE CONSTITUENT: 0.5 G/L HALOFUGINONE BASE (AS LACTATE SALT).
READ ENTIRE LABEL BEFORE USE.
INDICATIONS
In newborn calves:
- For the prevention of diarrhoea caused by _Cryptosporidium parvum_,
treatment should be
commenced within 24-48 hours post-birth.
- For the treatment of diarrhoea caused by _Cryptosporidium parvum_,
treatment should be
commenced within 24 hours after onset of diarrhoea.
DIRECTIONS FOR USE
PRECAUTIONS
For ORAL administration only - DO NOT INJECT.
Do not use on an empty stomach.
Do not use where diarrhoea has been established for more than 24 hours
and in weak
animals.
NOT FOR USE IN BOBBY CALVES.
For treatment of anorexic calves, the product should be administered
in half a litre of
electrolyte solution. Calves should receive enough colostrum according
to good breeding
practice.
SPECIAL PRECAUTIONS
As symptoms of toxicity may occur at 2 times the therapeutic dose, IT
IS IMPORTANT TO
STRICTLY ADHERE TO THE RECOMMENDED DOSE RATE. Symptoms of toxicity
include